Skip to content

Evaluation of AIT Study

Process-Outcome Study on Psychotherapeutic Interventions in Adolescents With Personality Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02518906
Enrollment
60
Registered
2015-08-10
Start date
2015-09-30
Completion date
2020-11-30
Last updated
2021-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder, Personality Disorders

Keywords

Psychotherapy, psychotherapy process, therapeutic alliance, psychotherapeutic change, psychophysiology

Brief summary

Specialized treatment of personality disorders (PD) in youth has been neglected for a long time, because these disorders were not diagnosed before the age of 18. Since 2013 the age threshold has been dropped in the Diagnostic and Statistical Manual (DSM)-5, and such change is also announced for the International Classification of Diseases (ICD)-11. There is broad consensus from both scientific evidence and clinical experience that specialized early interventions in adolescents with PD are urgently needed. In the last decades a number of specialized psychotherapeutic treatment programs have been developed. Despite their conceptual differences, many of the treatment models have shown significant effects in the treatment of PD in adults. However, the treatment of adolescents with PD remains difficult and further enhancement and development of treatments is needed. Given the different therapeutic approaches available, the present project aims to go beyond the comparison of integral therapeutic models in the classical outcome study design. While outcome research is important to build on the evidence of the effectiveness of an intervention, it contributes little to its understanding and refinement. The aim of the present multi-center project is to compare two therapeutic methods used in routine care: * Adolescent Identity Treatment (AIT) * Dialectic Behavioral Treatment for Adolescents (DBT-A) Treatments will be performed at different study centers and compared using the same measures of outcome. The main outcome will be psychosocial functioning. Additionally, the psychotherapy process will be investigated to explore specific and unspecific mechanisms of the therapeutic process, its outcome and mediators.

Interventions

BEHAVIORALAdolescent Identity Treatment

Integrative Approach for the treatment of adolescents with Personality Disorder. Manual was published in 2013.

BEHAVIORALDBT-A

Dialectic Behavioral Treatment for Adolescents is the most commonly used Approach for the Treatment of adolescents with Boderline Personality Disorder

Sponsors

Klaus Schmeck
Lead SponsorOTHER
Heidelberg University
CollaboratorOTHER
Pontificia Universidad Catolica de Chile
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Identity Diffusion (AIDA T-score \> 60) * borderline Criteria (SKID-II)

Exclusion criteria

* intelligence quotient (IQ) \< 80 * psychotic disorder * pervasive developmental disorders * heavy and persistent substance abuse * major somatic or neurological disease * hospital treatment

Design outcomes

Primary

MeasureTime frameDescription
Change in Children's Global Assessment Scale (CGAS)Baseline, 12 months after BaselinePsychosocial functioning. Rated considering the results of the Columbia Impairment Scale - parent and patient versions

Secondary

MeasureTime frameDescription
School functioningBaseline, 12 months after BaselineSchool Functioning Rating (SFR)
Change in PsychopathologyBaseline, 12 months after Baseline (only Basel and Heidelberg)Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
Change in Severity of PsychopathologyBaseline, 12 months after BaselineClinical Global Impression Scale
Change in DepressionBaseline, 12 months after BaselineBeck Depression Inventory (BDI)
Change in Psychopathological SymptomsBaseline, 12 months after BaselineStrengths & Difficulties Questionnaires (SDQ)
Change in Personality FunctioningBaseline, 12 months after Baseline (only Basel and Heidelberg)Levels of Personality Functioning - Questionnaire for Adolescents (LoPF-QA)
Change in IdentityBaseline, 12 months after BaselineAssessment of Identity Development in Adolescence (AIDA)
Change in Personality Disorder SymptomsBaseline, 12 months after Baseline (only Basel and Heidelberg)Structured Clinical Interview of Diagnostic and Statistical Manual of Mental Disorders (DSM) (SCID)-II
Psychosocial functioningBaseline, 12 months after BaselineColumbia Impairment Scale (CIS) (Patient and Parent versions)
Change in Mentalizing CapacityBaseline, 12 months after BaselineMovie for the Assessment of Social Cognition (MASC)
Change in Quality of LifeBaseline, 12 months after BaselineHealth-related Quality of Life Screening Instrument for Children and Adolescents (KIDSCREEN)
Change in Parental StressBaseline, 12 months after Baseline (only Basel and Heidelberg)Eltern-Belastungs-Inventar (EBI)
Self-injurious BehaviorBaseline, 12 months after Baseline (only Basel and Heidelberg)Self- Injurious Thoughts and Behaviors Interview
Borderline-specific Personality PathologyBaseline, 12 months after Baseline (only Basel and Heidelberg)Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD)
Borderline-specific SymptomsBaseline, 12 months after Baseline (only Basel and Santiago)Borderline Symptom List 23 (BSL-23)
Change in Psychophysiological Measures (Only Basel and Heidelberg)Baseline, 12 months after BaselineRegression analysis will be used to evaluate change; Parameters: Heart Rate Variability and Electrodermal Activity (Basel only)
Change in Hair Cortisol Level (only Basel and Heidelberg)Baseline, 12 months after Baseline
Change in Interpersonal ProblemsBaseline, 12 months after Baseline (only Santiago)Inventory of Interpersonal Problems (IIP-64)

Countries

Chile, Germany, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026